Procurement Summary
Country: Poland
Summary: Concentrate of Recombinant Coagulation Factor Viii at Least 2Nd Generation with Delivery to Regional Blood Donation and Blood Treatment Centers; Procedure Code: Zzp.Zp.411.116.2026 Parts: 1÷2
Deadline: 13 Aug 2026
Posting Date: 29 Jul 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 146139161
Document Ref. No.: 525962-2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33621000 - Medicinal products for the blood and blood-forming organs
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Part 1. Concentrate of recombinant coagulation factor VIII at least 2nd generation with delivery to Regional Blood Donation and Blood Treatment Centers. Part 2. Concentrate of recombinant coagulation factor VIII at least 2nd generation with delivery to Regional Blood Donation and Blood Treatment Centers. The subject of the order is the supply of a concentrate of recombinant coagulation factor VIII of at least the second generation to ensure the continuity of treatment of patients with hemophilia A - hereinafter referred to as "coagulation factor", availability categories Rp or Rpz, to direct recipients indicated by the National Blood Center (hereinafter NCK) or other authorized entity - Regional Blood Donation and Blood Treatment Centers (hereinafter RCKiK), on the terms specified in the content of SWZ. 1. Subject of the order is the supply of a concentrate of recombinant coagulation factor VIII of at least the second generation in order to secure the continuity of treatment of patients with hemophilia A - hereinafter referred to as "coagulation factor", with the availability category Rp or Rpz, to those indicated by the National Blood Center (hereinafter NCK) or other authorized entity direct recipients - Regional Blood Donation and Blood Treatment Centers (hereinafter RCKiK), on the terms specified in the SWZ content. 2. Total quantity (purchase quantity): 2, 500, 000 IU. 3. Dosage proportions in each delivery - in accordance with SWZ. 4. The clotting factor concentrate must be delivered with a kit enabling its administration. 5. When selecting the most advantageous offer, the Ordering Party reserves the right to...
Document Type: Contract Notice Reference Number: ZZP.ZP.411.116.2026 Contract Type: supplies Authority Type: cga Doc Title: Recombinant coagulation factor VIII minimum 2nd generation concentrate with delivery to Regional Blood Donation Centers and Blood therapy; procedure code: ZZP.ZP.411.116.2026 parts: 1÷2 Dispatch Date: 2026-07-27 Publish Date: 2026-07-29 Submission Date: 2026-08-13
Documents
Tender Notice